Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
UC Berkeley News
Wednesday, May 14, 2025 - 9:59am
tags:
legal, patents, Berkeley, CRISPR, gene editing
Germany’s Merck drops China surcharge on orders after US-China tariff deal
Pharma Live
Wednesday, May 14, 2025 - 9:53am
tags:
Merck KGaA, China, tariffs
Bayer’s continued restructuring claims 2,000 jobs and thins management layers
BioSpace
Wednesday, May 14, 2025 - 9:50am
tags:
Bayer, Europe, innovation, Bill Anderson, layoffs, restructuring
Trump’s ‘most favored nation’ policy is back. Here’s why it failed the first time.
Pharma Voice
Wednesday, May 14, 2025 - 9:47am
tags:
Donald Trump, most favored nation, drug pricing
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
BioSpace
Wednesday, May 14, 2025 - 9:46am
tags:
GSK, Boston Pharmaceuticals, efimosfermin alfa, MASH
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Fierce Biotech
Tuesday, May 13, 2025 - 11:27am
tags:
GSK, anti-TIGIT, belrestotug, iTeos Therapeutics
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
The Guardian, UK
Tuesday, May 13, 2025 - 11:24am
tags:
Elizabeth Holmes, Theranos, diagnostics, funding, Haemanthus, Billy Evans
Cytokinetics (CYTK) Rallies as Phase 3 Trial Succeeds for Lead Drug
Guru Focus
Tuesday, May 13, 2025 - 11:19am
tags:
Cytokinetics, aficamten, clinical trials, obstructive hypertrophic cardiomyopathy
Bluebird bio warns of potential bankruptcy after another buyout delay
Fierce Pharma
Tuesday, May 13, 2025 - 11:16am
tags:
Bluebird Bio, bankruptcy, M&A, gene therapy
UnitedHealth Group CEO Andrew Witty steps down, company suspends annual forecast
CNBC
Tuesday, May 13, 2025 - 11:13am
tags:
Unitedhealth Group, Andrew Witty, insurers
J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus
Fierce Biotech
Tuesday, May 13, 2025 - 11:10am
tags:
Stylus Medicine, funding, JNJ, Eli Lilly, gene editing
Pharmacists stockpile most common drugs on chance of targeted Trump tariffs
NPR
Tuesday, May 13, 2025 - 11:08am
tags:
pharmacists, tariffs
HIV market expected to reach $32.1bn by 2033 in 7MM
Clinical Trials Arena
Tuesday, May 13, 2025 - 11:06am
tags:
HIV
FDA's plan to roll out AI agencywide raises questions
Axios
Tuesday, May 13, 2025 - 11:03am
tags:
FDA, artificial intelligence, genAI
Galapagos drops plan to split after 'market developments'
Pharmaphorum
Tuesday, May 13, 2025 - 11:01am
tags:
Galapagos, cell therapy
Bayer CEO confident firm can cope with Xarelto hit
Pharmaphorum
Tuesday, May 13, 2025 - 10:57am
tags:
Bayer, Pharma CEOs, Bill Anderson, Xarelto, earnings
Medicare lays out timeline for third round of drug price negotiations
MSN/Reuters
Monday, May 12, 2025 - 10:04pm
tags:
Medicare, drug pricing
Abeona sells speedy drug review voucher for $155M
BioPharma Dive
Monday, May 12, 2025 - 10:00pm
tags:
Abeona Therapeutics, priority review voucher
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
Motley Fool
Monday, May 12, 2025 - 9:58pm
tags:
Teva Pharmaceutical, JPMorgan Chase
GOP unveils transparent PBM pricing model
Beckers Hospital Review
Monday, May 12, 2025 - 9:54pm
tags:
PBMs, drug pricing, legislation, Republicans

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.